Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
We compare value-focused dividend growth ETFs to help you spot the best option based on cost, yield, and growth potential.
27,266 articlesPfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
CryptoQuant urges Strategy to pause BTC purchases amid cash strain and ballooning dividends, signaling a potential sh...
The latest inflation data show a notable rise that marks the highest level in years. As investors, we can parse the s...
Investors chase value, momentum and income as markets wobble in July 2026. This report breaks down the retirement por...
With the Fed signaling restraint on rate moves in 2026, three ETFs stand out as bets that thrive when policy stays st...
A fresh analysis shows WisdomTree's WCLD underperforms due to equal-weight rebalancing, turning a $10,000 stake into ...
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
XRP nears a critical support area that traders call a buying opportunity. Analysts outline a potential rebound to $3 ...
When markets slide, value-minded investors can find hedges and growth tucked into solid fundamentals. Learn a simple,...
Momentum can tilt a portfolio toward recent winners. This article explains how two Vanguard ETFs using momentum aim t...
A disciplined approach using SPYI could deliver about $100 in monthly cash from a $10,000 investment, driven by optio...
Bitcoin staged a striking break from a long-standing pattern, defying a rising dollar as ETF inflows surged. Analysts...